On the other hand, there is a growing interest in the study of myokines, in particular myostatin, as therapeutic targets for the treatment of skeletal muscle wasting/atrophy under diverse clinical settings, including denervation, AIDS, cancer, diabetes, and chronic heart failure [22]. This evidence concerns the gene MSTN and diabetes mellitus.